{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:40:45Z","timestamp":1794613245467,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/RC\/3948"],"award-info":[{"award-number":["16\/RC\/3948"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["RG94424"],"award-info":[{"award-number":["RG94424"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["RG83195"],"award-info":[{"award-number":["RG83195"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["G106133"],"award-info":[{"award-number":["G106133"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["109967\/Z\/15\/Z"],"award-info":[{"award-number":["109967\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["RG83195"],"award-info":[{"award-number":["RG83195"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SBF004\/1099"],"award-info":[{"award-number":["SBF004\/1099"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C57799\/A27964"],"award-info":[{"award-number":["C57799\/A27964"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Resistance to standard and novel therapies remains the main obstacle to cure in acute myeloid leukaemia (AML) and is often driven by metabolic adaptations which are therapeutically actionable. Here we identify inhibition of mannose-6-phosphate isomerase (MPI), the first enzyme in the mannose metabolism pathway, as a sensitizer to both cytarabine and FLT3 inhibitors across multiple AML models. Mechanistically, we identify a connection between mannose metabolism and fatty acid metabolism, that is mediated via preferential activation of the ATF6 arm of the unfolded protein response (UPR). This in turn leads to cellular accumulation of polyunsaturated fatty acids, lipid peroxidation and ferroptotic cell death in AML cells. Our findings provide further support to the role of rewired metabolism in AML therapy resistance, unveil a connection between two apparently independent metabolic pathways and support further efforts to achieve eradication of therapy-resistant AML cells by sensitizing them to ferroptotic cell death.<\/jats:p>","DOI":"10.1038\/s41467-023-37652-0","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T06:01:58Z","timestamp":1681452118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death"],"prefix":"10.1038","volume":"14","author":[{"given":"Keith","family":"Woodley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Dillingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-6592","authenticated-orcid":false,"given":"George","family":"Giotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1959-8199","authenticated-orcid":false,"given":"Pedro","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Rattigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8546-3893","authenticated-orcid":false,"given":"C\u00e9line","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9463-253X","authenticated-orcid":false,"given":"Vilma","family":"Dembitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife M. S.","family":"Magee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Asby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-1557","authenticated-orcid":false,"given":"Louie N.","family":"van de Lagemaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2059-7006","authenticated-orcid":false,"given":"Christopher","family":"Mapperley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie C.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen H. M.","family":"Prehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4865-7648","authenticated-orcid":false,"given":"Konstantinos","family":"Tzelepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7671-7364","authenticated-orcid":false,"given":"Kevin","family":"Rouault-Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-8022","authenticated-orcid":false,"given":"George S.","family":"Vassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7547-4989","authenticated-orcid":false,"given":"Kamil R.","family":"Kranc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-132X","authenticated-orcid":false,"given":"G. Vignir","family":"Helgason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-161X","authenticated-orcid":false,"given":"Brian J. P.","family":"Huntly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-2253","authenticated-orcid":false,"given":"Paolo","family":"Gallipoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"37652_CR1","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/ajh.25975","volume":"95","author":"EH Estey","year":"2020","unstructured":"Estey, E. H. Acute myeloid leukemia: 2021 update on risk-stratification and management. Am. J. Hematol. 95, 1368\u20131398 (2020).","journal-title":"Am. J. Hematol."},{"key":"37652_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature11016","volume":"485","author":"CC Smith","year":"2012","unstructured":"Smith, C. C. et al. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature 485, 260\u2013263 (2012).","journal-title":"Nature"},{"key":"37652_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-018-0251-7","volume":"559","author":"AM Intlekofer","year":"2018","unstructured":"Intlekofer, A. M. et al. Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations. Nature 559, 125\u2013129 (2018).","journal-title":"Nature"},{"key":"37652_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ccell.2021.05.015","volume":"39","author":"O Marin-Bejar","year":"2021","unstructured":"Marin-Bejar, O. et al. Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma. Cancer Cell 39, 1135\u20131149 e1138 (2021).","journal-title":"Cancer Cell"},{"key":"37652_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature14888","volume":"525","author":"CY Fong","year":"2015","unstructured":"Fong, C. Y. et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature 525, 538\u2013542 (2015).","journal-title":"Nature"},{"key":"37652_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","volume":"19","author":"S Boumahdi","year":"2020","unstructured":"Boumahdi, S. & de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. Nat. Rev. Drug Disco. 19, 39\u201356 (2020).","journal-title":"Nat. Rev. Drug Disco."},{"key":"37652_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2020.10.001","volume":"27","author":"R Culp-Hill","year":"2021","unstructured":"Culp-Hill, R., D\u2019Alessandro, A. & Pietras, E. M. Extinguishing the embers: targeting AML metabolism. Trends Mol. Med 27, 332\u2013344 (2021).","journal-title":"Trends Mol. Med"},{"key":"37652_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1158\/2159-8290.CD-20-0738","volume":"11","author":"S Bjelosevic","year":"2021","unstructured":"Bjelosevic, S. et al. Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-driven acute myeloid leukemia. Cancer Disco. 11, 1582\u20131599 (2021).","journal-title":"Cancer Disco."},{"key":"37652_CR9","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2017-12-820035","volume":"131","author":"P Gallipoli","year":"2018","unstructured":"Gallipoli, P. et al. Glutaminolysis is a metabolic dependency in FLT3(ITD) acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition. Blood 131, 1639\u20131653 (2018).","journal-title":"Blood"},{"key":"37652_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou, E. D. et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12, 329\u2013341 (2013).","journal-title":"Cell Stem Cell"},{"key":"37652_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio, I. et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest 120, 142\u2013156 (2010).","journal-title":"J. Clin. Invest"},{"key":"37652_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature24294","volume":"551","author":"S Raffel","year":"2017","unstructured":"Raffel, S. et al. BCAT1 restricts alphaKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature 551, 384\u2013388 (2017).","journal-title":"Nature"},{"key":"37652_CR13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge, T. et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Disco. 7, 716\u2013735 (2017).","journal-title":"Cancer Disco."},{"key":"37652_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbrc.2014.06.021","volume":"453","author":"V Sharma","year":"2014","unstructured":"Sharma, V., Ichikawa, M. & Freeze, H. H. Mannose metabolism: more than meets the eye. Biochem Biophys. Res Commun. 453, 220\u2013228 (2014).","journal-title":"Biochem Biophys. Res Commun."},{"key":"37652_CR15","doi-asserted-by":"publisher","first-page":"6751","DOI":"10.1074\/jbc.M113.544064","volume":"289","author":"M Ichikawa","year":"2014","unstructured":"Ichikawa, M., Scott, D. A., Losfeld, M. E. & Freeze, H. H. The metabolic origins of mannose in glycoproteins. J. Biol. Chem. 289, 6751\u20136761 (2014).","journal-title":"J. Biol. Chem."},{"key":"37652_CR16","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1074\/jbc.M511982200","volume":"281","author":"C DeRossi","year":"2006","unstructured":"DeRossi, C. et al. Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethality. J. Biol. Chem. 281, 5916\u20135927 (2006).","journal-title":"J. Biol. Chem."},{"key":"37652_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1006\/bbrc.1998.8385","volume":"245","author":"TJ de Koning","year":"1998","unstructured":"de Koning, T. J. et al. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys. Res Commun. 245, 38\u201342 (1998).","journal-title":"Biochem Biophys. Res Commun."},{"key":"37652_CR18","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1086\/301873","volume":"62","author":"J Jaeken","year":"1998","unstructured":"Jaeken, J. et al. Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am. J. Hum. Genet 62, 1535\u20131539 (1998).","journal-title":"Am. J. Hum. Genet"},{"key":"37652_CR19","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1172\/JCI2350","volume":"101","author":"R Niehues","year":"1998","unstructured":"Niehues, R. et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J. Clin. Invest 101, 1414\u20131420 (1998).","journal-title":"J. Clin. Invest"},{"key":"37652_CR20","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1096\/fj.13-245514","volume":"28","author":"V Sharma","year":"2014","unstructured":"Sharma, V. et al. Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice. FASEB J. 28, 1854\u20131869 (2014).","journal-title":"FASEB J."},{"key":"37652_CR21","doi-asserted-by":"publisher","first-page":"e22477","DOI":"10.7554\/eLife.22477","volume":"6","author":"N Shtraizent","year":"2017","unstructured":"Shtraizent, N. et al. MPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect. Elife 6, e22477 (2017).","journal-title":"Elife"},{"key":"37652_CR22","doi-asserted-by":"publisher","first-page":"e110345","DOI":"10.1371\/journal.pone.0110345","volume":"9","author":"A Cazet","year":"2014","unstructured":"Cazet, A., Charest, J., Bennett, D. C., Sambrooks, C. L. & Contessa, J. N. Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity. PLoS One 9, e110345 (2014).","journal-title":"PLoS One"},{"key":"37652_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41586-018-0729-3","volume":"563","author":"PS Gonzalez","year":"2018","unstructured":"Gonzalez, P. S. et al. Mannose impairs tumour growth and enhances chemotherapy. Nature 563, 719\u2013723 (2018).","journal-title":"Nature"},{"key":"37652_CR24","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/bloodadvances.2020003443","volume":"5","author":"S Pacharne","year":"2021","unstructured":"Pacharne, S. et al. SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML. Blood Adv. 5, 2412\u20132425 (2021).","journal-title":"Blood Adv."},{"key":"37652_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nm.4125","volume":"22","author":"S Li","year":"2016","unstructured":"Li, S. et al. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nat. Med. 22, 792\u2013799 (2016).","journal-title":"Nat. Med"},{"key":"37652_CR26","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1056\/NEJMoa1808777","volume":"379","author":"MJ Christopher","year":"2018","unstructured":"Christopher, M. J. et al. Immune escape of relapsed AML cells after allogeneic transplantation. N. Engl. J. Med. 379, 2330\u20132341 (2018).","journal-title":"N. Engl. J. Med."},{"key":"37652_CR27","doi-asserted-by":"publisher","first-page":"39431","DOI":"10.1074\/jbc.M111.285502","volume":"286","author":"V Sharma","year":"2011","unstructured":"Sharma, V. et al. Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts. J. Biol. Chem. 286, 39431\u201339438 (2011).","journal-title":"J. Biol. Chem."},{"key":"37652_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.leukres.2005.02.015","volume":"29","author":"G Perea","year":"2005","unstructured":"Perea, G. et al. Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients. Leuk. Res 29, 1109\u20131116 (2005).","journal-title":"Leuk. Res"},{"key":"37652_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1023\/A:1020539932353","volume":"239","author":"SL Coort","year":"2002","unstructured":"Coort, S. L. et al. Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT\/CD36)-mediated cellular fatty acid uptake. Mol. Cell Biochem 239, 213\u2013219 (2002).","journal-title":"Mol. Cell Biochem"},{"key":"37652_CR30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1017\/S1751731112001619","volume":"7","author":"J Guo","year":"2013","unstructured":"Guo, J. et al. Selective transport of long-chain fatty acids by FAT\/CD36 in skeletal muscle of broilers. Animal 7, 422\u2013429 (2013).","journal-title":"Animal"},{"key":"37652_CR31","doi-asserted-by":"publisher","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","volume":"314","author":"R Lakhia","year":"2018","unstructured":"Lakhia, R. et al. PPARalpha agonist fenofibrate enhances fatty acid beta-oxidation and attenuates polycystic kidney and liver disease in mice. Am. J. Physiol. Ren. Physiol. 314, F122\u2013F131 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"37652_CR32","doi-asserted-by":"publisher","first-page":"11354","DOI":"10.1074\/jbc.M309804200","volume":"279","author":"M Hong","year":"2004","unstructured":"Hong, M. et al. Underglycosylation of ATF6 as a novel sensing mechanism for activation of the unfolded protein response. J. Biol. Chem. 279, 11354\u201311363 (2004).","journal-title":"J. Biol. Chem."},{"key":"37652_CR33","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/ejn.13160","volume":"43","author":"K Nolan","year":"2016","unstructured":"Nolan, K. et al. Endoplasmic reticulum stress-mediated upregulation of miR-29a enhances sensitivity to neuronal apoptosis. Eur. J. Neurosci. 43, 640\u2013652 (2016).","journal-title":"Eur. J. Neurosci."},{"key":"37652_CR34","doi-asserted-by":"publisher","first-page":"e11880","DOI":"10.7554\/eLife.11880","volume":"5","author":"CM Gallagher","year":"2016","unstructured":"Gallagher, C. M. & Walter, P. Ceapins inhibit ATF6alpha signaling by selectively preventing transport of ATF6alpha to the Golgi apparatus during ER stress. Elife 5, e11880 (2016).","journal-title":"Elife"},{"key":"37652_CR35","doi-asserted-by":"publisher","first-page":"e11878","DOI":"10.7554\/eLife.11878","volume":"5","author":"CM Gallagher","year":"2016","unstructured":"Gallagher, C. M. et al. Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6alpha branch. Elife 5, e11878 (2016).","journal-title":"Elife"},{"key":"37652_CR36","doi-asserted-by":"publisher","first-page":"e15550","DOI":"10.7554\/eLife.15550","volume":"5","author":"L Plate","year":"2016","unstructured":"Plate, L. et al. Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation. Elife 5, e15550 (2016).","journal-title":"Elife"},{"key":"37652_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1534-5807(03)00022-4","volume":"4","author":"H Yoshida","year":"2003","unstructured":"Yoshida, H. et al. A time-dependent phase shift in the mammalian unfolded protein response. Dev. Cell 4, 265\u2013271 (2003).","journal-title":"Dev. Cell"},{"key":"37652_CR38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","volume":"107","author":"H Yoshida","year":"2001","unstructured":"Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881\u2013891 (2001).","journal-title":"Cell"},{"key":"37652_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.devcel.2007.07.005","volume":"13","author":"J Wu","year":"2007","unstructured":"Wu, J. et al. ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev. Cell 13, 351\u2013364 (2007).","journal-title":"Dev. Cell"},{"key":"37652_CR40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.kint.2018.09.023","volume":"95","author":"TM Jao","year":"2019","unstructured":"Jao, T. M. et al. ATF6alpha downregulation of PPARalpha promotes lipotoxicity-induced tubulointerstitial fibrosis. Kidney Int. 95, 577\u2013589 (2019).","journal-title":"Kidney Int"},{"key":"37652_CR41","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","volume":"37","author":"H Miess","year":"2018","unstructured":"Miess, H. et al. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene 37, 5435\u20135450 (2018).","journal-title":"Oncogene"},{"key":"37652_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou, Y. et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat. Commun. 10, 1617 (2019).","journal-title":"Nat. Commun."},{"key":"37652_CR43","doi-asserted-by":"publisher","first-page":"16768","DOI":"10.1074\/jbc.M601876200","volume":"281","author":"T Soga","year":"2006","unstructured":"Soga, T. et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J. Biol. Chem. 281, 16768\u201316776 (2006).","journal-title":"J. Biol. Chem."},{"key":"37652_CR44","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/cdd.2013.138","volume":"20","author":"S Dalleau","year":"2013","unstructured":"Dalleau, S., Baradat, M., Gueraud, F. & Huc, L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 20, 1615\u20131630 (2013).","journal-title":"Cell Death Differ."},{"key":"37652_CR45","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon, S. J. et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 3, e02523 (2014).","journal-title":"Elife"},{"key":"37652_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka, O. et al. On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death. ACS Cent. Sci. 3, 232\u2013243 (2017).","journal-title":"ACS Cent. Sci."},{"key":"37652_CR47","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/antiox10091347","volume":"10","author":"H Yuk","year":"2021","unstructured":"Yuk, H., Abdullah, M., Kim, D. H., Lee, H. & Lee, S. J. Necrostatin-1 prevents ferroptosis in a RIPK1- and IDO-independent manner in hepatocellular carcinoma. Antioxid. (Basel) 10, 1347 (2021).","journal-title":"Antioxid. (Basel)"},{"key":"37652_CR48","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1111\/cas.15138","volume":"112","author":"Y Saito","year":"2021","unstructured":"Saito, Y. et al. Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia. Cancer Sci. 112, 4944\u20134956 (2021).","journal-title":"Cancer Sci."},{"key":"37652_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nm.2548","volume":"18","author":"A Schneider","year":"2011","unstructured":"Schneider, A. et al. Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice. Nat. Med. 18, 71\u201373 (2011).","journal-title":"Nat. Med."},{"key":"37652_CR50","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2267-z","volume":"581","author":"EV Minikel","year":"2020","unstructured":"Minikel, E. V. et al. Evaluating drug targets through human loss-of-function genetic variation. Nature 581, 459\u2013464 (2020).","journal-title":"Nature"},{"key":"37652_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20164-6","volume":"11","author":"S Torretta","year":"2020","unstructured":"Torretta, S. et al. D-mannose suppresses macrophage IL-1beta production. Nat. Commun. 11, 6343 (2020).","journal-title":"Nat. Commun."},{"key":"37652_CR52","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/nm.4375","volume":"23","author":"D Zhang","year":"2017","unstructured":"Zhang, D. et al. D-mannose induces regulatory T cells and suppresses immunopathology. Nat. Med. 23, 1036\u20131045 (2017).","journal-title":"Nat. Med."},{"key":"37652_CR53","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1158\/1535-7163.MCT-15-0163","volume":"14","author":"C Larrue","year":"2015","unstructured":"Larrue, C. et al. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations. Mol. Cancer Ther. 14, 2364\u20132373 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"37652_CR54","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1182\/blood-2012-01-403493","volume":"120","author":"AB Williams","year":"2012","unstructured":"Williams, A. B. et al. Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3\/ITD leukemia. Blood 120, 3069\u20133079 (2012).","journal-title":"Blood"},{"key":"37652_CR55","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1182\/blood.2020008551","volume":"137","author":"M Tcheng","year":"2021","unstructured":"Tcheng, M. et al. Very long chain fatty acid metabolism is required in acute myeloid leukemia. Blood 137, 3518\u20133532 (2021).","journal-title":"Blood"},{"key":"37652_CR56","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","volume":"1","author":"BM Stevens","year":"2020","unstructured":"Stevens, B. M. et al. Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells. Nat. Cancer 1, 1176\u20131187 (2020).","journal-title":"Nat. Cancer"},{"key":"37652_CR57","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","volume":"2","author":"C Bosc","year":"2021","unstructured":"Bosc, C. et al. Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia. Nat. Cancer 2, 1204\u20131223 (2021).","journal-title":"Nat. Cancer"},{"key":"37652_CR58","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ccell.2021.06.003","volume":"39","author":"SK Joshi","year":"2021","unstructured":"Joshi, S. K. et al. The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance. Cancer Cell 39, 999\u20131014 e1018 (2021).","journal-title":"Cancer Cell"},{"key":"37652_CR59","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"37652_CR60","first-page":"273","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: A Regulated. Cell Death Nexus Link. Metab., Redox Biol., Dis. Cell 171, 273\u2013285 (2017).","journal-title":"Cell Death Nexus Link. Metab., Redox Biol., Dis. Cell"},{"key":"37652_CR61","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer, M. J. et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551, 247\u2013250 (2017).","journal-title":"Nature"},{"key":"37652_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35707-2","volume":"13","author":"Z Lin","year":"2022","unstructured":"Lin, Z. et al. The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis. Nat. Commun. 13, 7965 (2022).","journal-title":"Nat. Commun."},{"key":"37652_CR63","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 33, 1001\u20131012 e1005 (2021).","journal-title":"Cell Metab."},{"key":"37652_CR64","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors. Immunity 54, 1561\u20131577 e1567 (2021).","journal-title":"Immunity"},{"key":"37652_CR65","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V. & Fendt, S. M. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev. Cell 56, 1363\u20131393 (2021).","journal-title":"Dev. Cell"},{"key":"37652_CR66","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/ajcn\/72.4.905","volume":"72","author":"JP DeLany","year":"2000","unstructured":"DeLany, J. P., Windhauser, M. M., Champagne, C. M. & Bray, G. A. Differential oxidation of individual dietary fatty acids in humans. Am. J. Clin. Nutr. 72, 905\u2013911 (2000).","journal-title":"Am. J. Clin. Nutr."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37652-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37652-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37652-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T07:09:43Z","timestamp":1681456183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37652-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37652"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-37652-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.05.16.492042","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"assertion":[{"value":"20 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2132"}}